The Committee on Energy and Commerce is the oldest standing legislative committee (established 1795) in the U.S. House of Representatives and is vested with the broadest jurisdiction of any congressional authorizing committee. The Energy and Commerce Committee is at the forefront of all issues and policies powering America’s economy, including our global competitive edge in energy, technology, and health care. The committee is led by E&C Chairman Brett Guthrie (KY-02) and E&C Ranking Member Frank Pallone (NJ-06). The Subcommittee on Health is led by Chairman Morgan Griffith (VA-09) and Ranking Member Diana DeGette (C)-01).
<html>
<head><title>404 Not Found</title></head>
<body>
<center><h1>404 Not Found</h1></center>
<hr><center>nginx</center>
</body>
</html>
Today's markup consists of 10 bills addressing a range of important health issues.
The legislation before us reflects this subcommittee's efforts to improve public health outcomes,
enhance patient access, and modernize our health care delivery system
to better meet the challenges Americans face.
These bills represent thoughtful efforts from members on both sides of the aisle.
Several of the bills before us focus on reauthorizing critical public health
programs that support early detection and prevention that expire at the end of the fiscal
year. Marking up these reauthorizations gives us the ability to continue to support these
initiatives while also allowing us the opportunity to examine ways we can strengthen these programs.
This includes H.R. 4348, the Kay Hagan Tick Act reauthorization, which supports and enhances
programs for tick-borne disease research, prevention, and interagency coordination.
We will also consider H.R. 4541, the Breast Cancer Education and Awareness
Requires Learning Young Act, or the EARLY Act, which supports breast cancer detection
and education for young and high-risk women. Additionally, we will mark up the Accelerating
Access in Dementia and Alzheimer's Provider Act, or the ADAPT Act reauthorization, which seeks
to improve care through provider tools and training initiatives.
I also want to highlight H.R. 8205, the Accelerating Access to Critical Therapies
for ALS Act, which is before us this afternoon. Last month, I had the privilege of speaking
with the founders of IMALS, Brian Wallach and Sandra Abrevia, and participating alongside
them in a press conference held by Representative Quigley, who has done great work on this issue.
Their testimony before the subcommittee was both moving and insightful, and I especially
want to recognize that they had driven all the way from Chicago to be at our hearing
and advocate for this important program to support those with ALS.
We will also consider H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act,
which extends and funds national programs that facilitate bone marrow and cord blood
transplants for patients with blood cancers and other fatal diseases. In addition, we are marking
up H.R. 8209 legislation to reauthorize school-based health centers, which aim to strengthen
school-based health services and mental health access for students. We also have a couple of
FDA reform bills before us today, one of which is H.R. 2715, the Destruction of Hazardous Imports
Act, which gives the FDA the authority to destroy imported products that pose a significant public
health concern. The other is H.R. 2021, the FDA Modernization 3.0 Act, which directs the FDA to
fully implement policies established under FDA Modernization 2.0 to reduce unnecessary animal
testing for drug development. Lastly, we will mark up two bills from our Medicare patient access
hearing earlier this year, H.R. 1703, the Choices for Increased Mobility Act, which works to expand
access to titanium and carbon fiber wheelchairs for Medicare beneficiaries, while H.R. 5347, the
Health Care Efficiency through Flexibility Act, aims to improve health care reporting for accountable
care organizations. I am encouraged by the collaborative work that has gone into the
legislation before us today, and I want to thank all the members and staff who worked to bring
these bills to the subcommittee. I look forward to continuing to work on these policies and bringing
them to the full committee, and I am eager for a productive markup this afternoon.